Location History:
- Glomfjord, NO (2006)
- Oslo, NO (1994 - 2008)
Company Filing History:
4 out of 37 
2 out of 5 
1 out of 174 
Years Active: 1994-2008
Title: Innovating Photochemotherapy: The Contributions of Alf Bjorseth
Introduction
Alf Bjorseth, an accomplished inventor based in Oslo, Norway, has made significant strides in the field of photochemistry. With a portfolio of seven patents, he has contributed valuable innovations that play a crucial role in the diagnosis and treatment of various disorders through the use of photosensitizing agents.
Latest Patents
Two of Bjorseth's latest patents focus on esters of 5-aminolevulinic acid, which are utilized as photosensitizing agents in photochemotherapy. The first patent describes these compounds and their use in diagnosing and treating abnormalities of both external and internal surfaces of the body. The compounds of formula (I) R22N—CH2COCH2-CH2CO—OR1 represent a groundbreaking approach to photochemotherapy, facilitating the creation of products and kits designed for these therapeutic interventions. Similarly, his second patent also revolves around esters of 5-aminolevulinic acid, detailing compounds of formula (I) RN—CHCOCH—CHCO—OR, emphasizing their clinical applications in treating various disorders.
Career Highlights
Bjorseth's professional career has been marked by his roles in companies such as Photocure ASA and Photocure AS, where he has utilized his expertise to advance photochemistry technologies. His work has not only led to innovative commercial products but also to a deeper understanding of the application of chemicals in medical treatments.
Collaborations
Throughout his career, Bjorseth has collaborated with notable colleagues like Karl E Gierschcky and Johan E Moan. These partnerships have fostered an environment of innovation and creativity, propelling forward the research and application of photosensitizing agents.
Conclusion
Alf Bjorseth stands as a prominent figure in the realm of photochemistry, with his innovative patents paving the way for advancements in photochemotherapy. His contributions, alongside the collaborative efforts of his colleagues, highlight the importance of teamwork in achieving breakthroughs in medical treatments. Bjorseth's work not only impacts the scientific community but also has the potential to significantly enhance patient care.